Your browser doesn't support javascript.
loading
The activation of ERK1/2 via a tyrosine kinase pathway attenuates trail-induced apoptosis in HeLa cells.
Lee, Myoung Woo; Bach, Jae Hyung; Lee, Hyun Jung; Lee, Do Yeon; Joo, Wan Seok; Kim, Yong Sik; Park, Soon Cheol; Kim, Kyung Yong; Lee, Won Bok; Kim, Sung Su.
Afiliação
  • Lee MW; Department of Anatomy, College of Medicine, Chung-Ang University, Seoul, Korea.
Cancer Invest ; 23(7): 586-92, 2005.
Article em En | MEDLINE | ID: mdl-16305985
ABSTRACT
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) serves as an extracellular signal that triggers apoptosis in tumor cells. To characterize the molecular events involved in TRAIL-induced apoptotic signaling, we investigated the role of extracellular signal-regulated kinase 1/2 (ERK1/2) in HeLa cell death. Here we show that TRAIL-activated ERK1/2 through a tyrosine kinase-dependent pathway, subsequently elevated anti-apoptotic Bcl-2 protein levels. ERK1/2 inhibition with PD98059 promoted apoptotic cell death through the downregulation of ERK1/2 activity and Bcl-2 protein levels. Moreover, tyrosine kinase inhibition with Genistein in TRAIL-induced apoptosis effectively attenuated ERK1/2 activity and enhanced apoptotic cell death. Taken together, our results indicate that ERK1/2 activation via tyrosine kinase pathway plays a protective role as the cellular defense mechanism through the upregulation of Bcl-2 protein levels in TRAIL-induced apoptosis.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Fator de Necrose Tumoral alfa / Apoptose / Proteína Quinase 3 Ativada por Mitógeno / Proteínas Reguladoras de Apoptose Limite: Humans Idioma: En Revista: Cancer Invest Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Fator de Necrose Tumoral alfa / Apoptose / Proteína Quinase 3 Ativada por Mitógeno / Proteínas Reguladoras de Apoptose Limite: Humans Idioma: En Revista: Cancer Invest Ano de publicação: 2005 Tipo de documento: Article